News & Updates
Filter by Specialty:
Pegaspargase biosimilar safe to use in childhood ALL
The biosimilar Pegaspargase, when combined with chemotherapy, demonstrates a favourable safety profile in children with acute lymphoid leukemia (ALL) treated according to ICiCLe ALL-14 protocol, a study has shown.
Pegaspargase biosimilar safe to use in childhood ALL
05 Nov 2024
Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?
The use of sodium glucose cotransporter-2 (SGLT2) inhibitors nearly halves the risk of all-cause mortality at 3 years in patients with wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) and type 2 diabetes (T2D), findings from an observational study suggest.
Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?
05 Nov 2024
Opioid does little to ease pain in aSAH-related headache
Use of opioids results in small reductions in pain among adult patients with an aneurysmal subarachnoid haemorrhage (aSAH)-related headache, and higher doses do not appear to significantly boost its efficacy in relieving pain, according to a study.
Opioid does little to ease pain in aSAH-related headache
04 Nov 2024
Nonhormonal drug for hot flash scores big in two phase III trials
The novel neurokinin-1 and -3 receptor antagonist elinzanetant appears to reduce the frequency and severity of vasomotor symptoms (VMS), as well as improve sleep and menopause-related quality of life, as shown in two pivotal phase III trials.
